Company / Operating Cash Flow per Share
AbCellera Biologics Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.44
FY2025
5-year range
-$0.44 / $0.08
FY2021-FY2025
Trend
-18.9%
vs FY2024
Sector context
#97 of 212
Health Care
What the data says
At $-0.44, AbCellera Biologics Inc.'s operating cash flow per share ranks #97 of 212 in the Health Care sector. Operating Cash Flow per Share has declined for 3 consecutive years, from $0.08 in FY2022 to $-0.44 in FY2025.
Based on SEC 10-K filings.
-0.44 in FY2025.
Declined from $-0.15 to $-0.44 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#97 of 212 in Health CareTop 46% of 212This company -$0.44 Sector average $5.28
▼
-108.4% below sector average
Key checks
Key Insights
- AbCellera Biologics Inc.'s operating cash flow per share has declined for 3 consecutive years.
- In FY2025, operating cash flow per share decreased 18.9% year-over-year.
- Ranks #97 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.44 | -18.9% |
| FY2024 | -$0.37 | -144.0% |
| FY2023 | -$0.15 | -291.0% |
| FY2022 | $0.08 | +701.3% |
| FY2021 | $0.01 | -88.4% |
| FY2020 | $0.09 | +384.4% |
| FY2019 | $0.02 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026